Used in pharmaceutical research as a key intermediate in the synthesis of tyrosine kinase inhibitors, particularly for anticancer drug development. Shows activity in signaling pathway modulation, especially in targeting epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR). Also employed in the design of small-molecule inhibitors for treating solid tumors and hematological malignancies. Investigated for its potential in overcoming drug resistance in targeted cancer therapies. Additionally utilized in structure-activity relationship (SAR) studies to optimize potency and selectivity of kinase inhibitor candidates.